TEVA PHARMACEUTICAL INDUSTRIES LTD
TEVJF
|
$12.37
-24.22%
380
|
Health Technology
(0.0% 1d) (0.0% 1m) (48.1% 1y) (0.0% 2d) (0.0% 3d) (0.0% 7d) (83.09% volume)
Earnings Calendar:
Market Cap: $ 14,739,472,016
http://www.teva.co.il
Sec Filling | Patents | n/a employees
(IL) Teva Pharmaceutical Industries Ltd. engages in the development and production of medicines. Its products include medicines for cardiovascular diseases, pain relievers, obesity, cancer and supportive care, infectious diseases and human immunodeficiency viruses, and colds and coughs. The company was founded in 1901 and is headquartered in Petah Tikva, Israel.
cancer infectious disease pain relief israel cardiovascular
add to watch list Paper trade email alert is off
Ayala Pharmaceuticals, Inc.
AYLA
|
$0.5036
5.84%
-0.7%
0
|
Health Technology
(0.0% 1d) (0.0% 1m) (0.0% 1y) (0.0% 2d) (0.0% 3d) (0.0% 7d) (15.3% volume)
Earnings Calendar: 2022-11-14
Market Cap: $ 7,463,718
http://www.ayalapharma.com
Sec Filling | Patents | 29 employees
Ayala Pharmaceuticals, Inc. is a clinical-stage oncology. It is focused on the development and commercialization of small molecule therapeutics for patients suffering from rare and aggressive cancers. It also involved in in precision oncology, targeted therapy, drug development, companion diagnostics, and biomarkers. The company was founded in November 2017 and is headquartered in Rehovot, Israel.
cancer israel diagnostics
add to watch list Paper trade email alert is off
Compugen Ltd.
CGEN
|
$2.03
3.57%
3.45%
450K
|
Health Technology
(0.0% 1d) (-14.9% 1m) (269.4% 1y) (0.0% 2d) (0.0% 3d) (0.0% 7d) (-100.0% volume)
Earnings Calendar: 2023-11-07
Market Cap: $ 181,152,054
http://www.cgen.com
Sec Filling | Patents | 61 employees
Compugen Ltd. engages in the research, development, and commercialization of therapeutic and diagnostic biomarker product candidates including proteins and monoclonal antibodies. It focuses its research and development on immuno-oncology and autoimmune diseases. The company was founded by Eli Mintz, Simchon Faigler, and Amir Natan on February 10, 1993 and is headquartered in Holon, Israel.
antibody autoimmunity monoclonal antibodies israel diagnostics
add to watch list Paper trade email alert is off
Evogene Ltd.
EVGN
|
$0.7
-13.64%
63K
|
Health Technology
(0.0% 1d) (-5.7% 1m) (23.5% 1y) (0.0% 2d) (-0.9% 3d) (0.0% 7d) (NaN% volume)
Earnings Calendar: 2024-03-07
Market Cap: $ 35,409,422
http://www.evogene.com
Sec Filling | Patents | 143 employees
Evogene Ltd. engages in the development and commercialization of a computer-biological platform for improving the development processes of products in the field of life sciences. It operates through the following segments: Agriculture, Industry, and Human. The Agriculture segment engages in the development of seed traits, agrochemical products, and agrobiological products to improve plant performance. The Industry segment engages in the development of castor bean seeds to serve as a feedstock source for biofuel and other industrial uses. The Human segment engages in the discovery and development of human microbiome-based therapeutics. The company was founded by Amir Barzilay and Hagai Karchi on October 10, 1999 and is headquartered in Rehovot, Israel.
seeds computational israel agricultural msa agriculture
add to watch list Paper trade email alert is off
Medigus Ltd.
MDGS
|
$2.48
13.78%
12.11%
25K
|
Health Technology
(0.0% 1d) (-14.0% 1m) (-60.5% 1y) (0.0% 2d) (0.0% 3d) (5.8% 7d) (174.81% volume)
Earnings Calendar:
Market Cap: $ 25,325,336
http://www.medigus.com
Sec Filling | Patents | 20 employees
(IL) Medigus Ltd. engages in research and development of medical treatment for the gastrointestinal tract. Its product is the MUSE system, an endoscopic device to perform Transoral Fundoplication for the treatment of gastroesophageal reflux disease. The company was founded by Elazar Sonnenschein on December 9, 1999 and is headquartered in Omer, Israel.
gastrointestinal endoscopy israel treatment
add to watch list Paper trade email alert is off
Pluristem Therapeutics, Inc.
PSTI
|
$1.0
-2.91%
8.0%
|
Health Technology
(0.0% 1d) (0.0% 1m) (0.0% 1y) (0.0% 2d) (0.0% 3d) (0.0% 7d) (192.0% volume)
Earnings Calendar: 2022-09-12
Market Cap: $ 32,347,584
http://www.pluristem.com
Sec Filling | Patents | 146 employees
(IL) Pluristem Therapeutics, Inc. is a clinical stage company, which engages in cell therapy development. It develops placenta-based cell therapy product candidates for the treatment of multiple ischemic, inflammatory and hematologic conditions. The firm focuses on the development, clinical trials and manufacturing of cell therapeutics and related technologies. Its products include Clinical Pipeline, PLX-Immune, PLX-PAD, and PLX-R18. The company was founded by Doron Shorrer on May 11, 2001 and is headquartered in Haifa, Israel.
israel t-cell clinical trials treatment ceiling
add to watch list Paper trade email alert is off
BioLineRx Ltd.
BLRX
|
$0.6401
3.01%
3.07%
1.9K
|
Health Technology
(0.0% 1d) (-46.2% 1m) (-41.3% 1y) (0.0% 2d) (1.3% 3d) (-0.0% 7d) (Infinity% volume)
Earnings Calendar:
Market Cap: $ 51,169,132
http://www.biolinerx.com
Sec Filling | Patents | 42 employees
(IL) BioLineRx Ltd. is a clinical stage biopharmaceutical company focused on oncology. The company was founded in April 2003 and is headquartered in Modi'in, Israel.
israel
add to watch list Paper trade email alert is off
Redhill Biopharma Ltd.
RDHL
|
$0.4208
9.16%
10.37%
26K
|
Health Technology
(0.0% 1d) (-22.5% 1m) (-86.1% 1y) (0.0% 2d) (0.0% 3d) (-3.5% 7d) (-75.52% volume)
Earnings Calendar:
Market Cap: $ 371,036
http://www.redhillbio.com
Sec Filling | Patents | 182 employees
(IL) RedHill Biopharma Ltd. is a biopharmaceutical company focusing on the development and commercialization of proprietary drugs for the treatment of gastrointestinal diseases. It operates through the Commercial Operations segment and the Research & Development segment. The Commercial Operations segment covers all areas relating to the commercial sales and operating expenses directly related to that activity and is being performed by the Company’s subsidiary in the United States. The Research & Development segment includes all activities related to the research and development of therapeutic candidates. The company was founded by Dror Ben-Asher and Ori Shilo on August 3, 2009 and is headquartered in Tel Aviv, Israel.
gastrointestinal israel urea treatment
add to watch list Paper trade email alert is off
Galmed Pharmaceuticals Ltd.
GLMD
|
$0.3787
2.8%
-0.41%
2.2K
|
Health Technology
(0.0% 1d) (21.4% 1m) (-99.5% 1y) (0.0% 2d) (0.0% 3d) (-1.6% 7d) (-52.02% volume)
Earnings Calendar: 2022-11-07
Market Cap: $ 1,910,664
http://www.galmedpharma.com
Sec Filling | Patents | 21 employees
(IL) Galmed Pharmaceuticals Ltd. is a clinical-stage biopharmaceutical company, which engages in the development of oral therapy for the treatment of non-alcoholic steato-hepatitis (NASH). Its product candidate, Aramchol, is a synthetic fatty acid-bile acid conjugate molecule for the oral treatment of NASH in patients who are overweight or obese and have prediabetes or type II diabetes mellitus. The company was founded by Allen Baharaff and Tuvia Gilat in 2000 and is headquartered in Tel Aviv, Israel.
diabetes diabetic israel hepatitis nash treatment
add to watch list Paper trade email alert is off
Check-Cap Ltd.
CHEK
|
$2.26
3.67%
3.54%
1
|
Health Technology
(0.0% 1d) (9.7% 1m) (63.8% 1y) (0.0% 2d) (0.0% 3d) (3.7% 7d) (218.69% volume)
Earnings Calendar: 2022-11-02
Market Cap: $ 13,214,195
http://www.check-cap.com
Sec Filling | Patents | 64 employees
(IL) Check-Cap Ltd. is a clinical stage medical diagnostics company engaging in the development of ingestible imaging capsule system for colorectal cancer screening. The company was founded by Yoav Kimchy in April 2005 and is headquartered in Isfiya, Israel.
cancer colorectal cancer israel diagnostics
add to watch list Paper trade email alert is off
PainReform Ltd.
PRFX
|
News
0
d
|
$0.89
-2.29%
-4.58%
1.4K
|
Health Technology
(0.0% 1d) (-54.6% 1m) (-84.7% 1y) (0.0% 2d) (-4.3% 3d) (-19.0% 7d) (-100.0% volume)
Earnings Calendar: 2022-11-14
Market Cap: $ 1,803,356
http://www.painreform.com
Sec Filling | Patents | n/a employees
PainReform Ltd. operates as a pharmaceutical company. It develops and markets pharmaceuticals. The firm focuses on developing reformulation of pain therapeutics, PainReform applies its propriety formulation technologies to prolong and enhance efficacy, reduce adverse effects shortening recovery time and reduce the need of augmentation with drugs such as opioids and NSAIDS. The company was founded by Lihu Avitov and Dan Teleman in 2007 and is headquartered in Herzliya, Israel.
education opioid israel msa
add to watch list Paper trade email alert is off
XTL Biopharmaceuticals Ltd.
XTLB
|
$2.44
-1.21%
-7.0%
26
|
Health Technology
(0.0% 1d) (3.8% 1m) (94.5% 1y) (0.0% 2d) (0.0% 3d) (-7.8% 7d) (18.02% volume)
Earnings Calendar:
Market Cap: $ 6,690,622
http://www.xtlbio.com
Sec Filling | Patents | 4 employees
(US) XTL Biopharmaceuticals Ltd. focuses on the acquisition and development of proprietary products and late-stage pharmaceutical product candidates for the treatment of unmet clinical needs. The company was founded on March 9, 1993 and is headquartered in Raanana, Israel.
acquisitions israel treatment
add to watch list Paper trade email alert is off
Entera Bio Ltd.
ENTX
|
$2.24
0.9%
1.33%
120
|
Health Technology
(0.0% 1d) (47.4% 1m) (163.6% 1y) (0.0% 2d) (0.0% 3d) (-11.1% 7d) (-69.73% volume)
Earnings Calendar: 2022-11-09
Market Cap: $ 79,478,204
http://www.enterabio.com
Sec Filling | Patents | 24 employees
(IL) Entera Bio Ltd. is a clinical-stage biopharmaceutical company, which focuses on the development and commercialization of orally delivered large molecule therapeutics. It develops an oral formulation of parathyroid hormone. The company was founded on June 1, 2010 and is headquartered in Jerusalem, Israel.
hormone israel osteoporosis eb613 bone
add to watch list Paper trade email alert is off
DarioHealth Corp.
DRIO
|
$1.15
-4.96%
-5.68%
10
|
Health Technology
(0.0% 1d) (-16.4% 1m) (-67.9% 1y) (0.0% 2d) (0.0% 3d) (2.6% 7d) (-76.21% volume)
Earnings Calendar: 2024-03-07
Market Cap: $ 33,858,912
http://www.dariohealth.com
Sec Filling | Patents | 72 employees
DarioHealth Corp. is a digital therapeutics company, which engages in the research, development, and sale of pharmaceutical products. It offers a monitoring device, mobile application, and data services for diabetes management. Its solutions include MyDario, Daro Engage, and Dario Intelligence. The company was founded by Oren Fuerst, Shoshana Friedman, David Weintraub, Dov Oppenheim, and Shilo Ben Zeev on August 11, 2011 and is headquartered in Caesarea, Israel.
diabetes diabetic israel monitoring device
add to watch list Paper trade email alert is off
NanoVibronix, Inc.
NAOV
4
|
$0.75
0.61%
0
|
Health Technology
(0.0% 1d) (-16.7% 1m) (-77.6% 1y) (0.0% 2d) (0.0% 3d) (-6.3% 7d) (-85.7% volume)
Earnings Calendar:
Market Cap: $ 2,088,266
http://www.nanovibronix.com
Sec Filling | Patents | 10 employees
(US) NanoVibronix, Inc. engages in the development of noninvasive biological response-activating devices. It targets wound healing and pain therapy, and can be administered at home, without the assistance of medical professionals. Its products include WoundShield, PainShield, and UroShield. It operates through the following geographical segments: United States, Israel, United Kingdom, European Union, India, and Other. The company was founded by Harold Jacob and Jona Zumeris in September 2003 and is headquartered in Melville, NY.
israel uroshield painshield
add to watch list Paper trade email alert is off
PolyPid Ltd.
PYPD
|
$4.3
-3.15%
-3.26%
0
|
Health Technology
(0.0% 1d) (-2.1% 1m) (957.4% 1y) (0.0% 2d) (0.0% 3d) (-1.3% 7d) (33.71% volume)
Earnings Calendar: 2024-02-14
Market Cap: $ 20,628,184
http://www.polypid.com
Sec Filling | Patents | 58 employees
PolyPid Ltd. is a clinical stage biopharmaceutical company focusing on the development, manufacture, and commercialization of administered therapies to improve surgical outcomes. The company was founded by Noam Emanuel in 2008 and is headquartered in Petach Tikva, Israel.
israel
add to watch list Paper trade email alert is off
InspireMD Inc.
NSPR
4
|
$2.1409
-3.13%
-1.81%
0
|
Health Technology
(0.0% 1d) (-4.3% 1m) (118.8% 1y) (0.0% 2d) (0.0% 3d) (-2.6% 7d) (41.96% volume)
Earnings Calendar: 2022-11-07
Market Cap: $ 50,218,214
http://www.inspiremd.com
Sec Filling | Patents | 48 employees
InspireMD, Inc. is a medical device company, which engages in the development and commercialization of the stent platform technology for the treatment of complex vascular and coronary disease. Its products are marketed for use mainly in patients with acute coronary syndromes, notably acute myocardial infarction and saphenous vein graft coronary interventions. The company was founded in 2005 and is headquartered in Tel Aviv, Israel.
israel treatment
add to watch list Paper trade email alert is off
CollPlant Biotechnologies Ltd.
CLGN
|
$5.22
-0.38%
-2.54%
0
|
Health Technology
(0.0% 1d) (0.0% 1m) (-26.3% 1y) (0.0% 2d) (0.0% 3d) (-0.3% 7d) (-32.14% volume)
Earnings Calendar: 2024-03-29
Market Cap: $ 59,782,948
http://www.collplant.com
Sec Filling | Patents | 46 employees
(IL) CollPlant Biotechnologies Ltd. is a regenerative medicine company, which engages in the research, development, manufacture, and marketing of medical products for tissue repair such as bioprinting of tissues and organs, and medical aesthetics. The company's products include VergenixSTR, VergenixFG, and CollPlant Surgical Matrix. The company was founded by Oded Shoseyov in June 2004 and is headquartered in Rehovot, Israel.
israel aesthetic
add to watch list Paper trade email alert is off
Kamada Ltd.
KMDA
|
$5.1
0.39%
-0.1%
0
|
Health Technology
(0.0% 1d) (-13.2% 1m) (13.2% 1y) (0.0% 2d) (0.0% 3d) (0.0% 7d) (NaN% volume)
Earnings Calendar: 2024-03-13
Market Cap: $ 293,116,467
http://www.kamada.com
Sec Filling | Patents | 429 employees
Kamada Ltd. engages in the development and production of pharmaceutical products. It operates through the Proprietary Products segment and the Distribution segment. The Proprietary Products segment covers the development, manufacture, and sale of plasma-derived protein therapeutics products. The Distribution segment covers the supply of plasma-based products for clinical use. The company was founded by David Tsur and Ralf Hahn on December 13, 1990 and is headquartered in Rehovot, Israel.
israel
add to watch list Paper trade email alert is off
Taro Pharmaceutical Industries Ltd.
TARO
|
$42.19
-0.12%
0.0%
0
|
Health Technology
(0.0% 1d) (-0.2% 1m) (66.7% 1y) (0.0% 2d) (0.0% 3d) (0.3% 7d) (-27.74% volume)
Earnings Calendar:
Market Cap: $ 1,585,695,582
http://www.taro.com
Sec Filling | Patents | 1464 employees
Taro Pharmaceutical Industries Ltd. engages in the development, manufacturing and marketing of prescribed and over-the-counter pharmaceutical products in the U.S., Canada and Israel. Its products include semi-solids formulations, such as creams and ointments and other dosage forms such as liquids, capsules and tablets, in the dermatological and topical, cardiovascular, neuropsychiatric and anti-inflammatory therapeutic categories. The company was founded in 1950 and is headquartered in Haifa Bay, Israel.
cardiovascular israel neuropsychiatric
add to watch list Paper trade email alert is off
Your Today's Watch List
Sign in to create a watchlistGainers vs Losers
| 62% | 38% |
Top 10 Gainers
AGBA | News | $1.4 250.0% 35M
|
Finance
RWOD | $12.0 50.06% 3.9M
|
n/a
INDO | $4.9 20.1% 2.2M
|
Energy Minerals
NURO | $4.32 18.36% 66K
|
Health Technology
HUBC | $1.52 17.83% 4.7M
|
n/a
CARV 4 | $1.77 11.32% 8.5K
|
Finance
BROG | $1.23 10.81% 320K
|
Finance
PARA | $12.03 9.66% 5.8M
|
Information
ADAP | $0.98 9.08% 240K
|
Health Technology
POAI A | $1.25 8.69% 16K
|
Health Technology
Last 48 Hours Insiders Buying
ETST P 39000 | $0.068 4.61% -67.14% 0
|
Manufacturing
|
13:30
FNLC P 1275 | $22.16 -0.36% 0.34% 1
|
Finance
|
12:30
ADMQ | $0.0532 -4.14% -40.18% 0
|
|
10:30
AXR P 2400 | $22.17 2.69% 0.0% 0
|
Finance
|
21:00
QCRH P 118 | $55.41 1.34% 1.31% 0
|
Finance
|
18:01
VUZI P 7500 | $1.26 3.28% 3.17% 3.6K
|
Electronic Technology
|
18:00
RMCF | $3.5501 0.57% 2.22% 0
|
Consumer Non-Durables
|
20:10